Moderna, Inc. (FRA:0QF)
29.53
+0.54 (1.85%)
At close: Jan 9, 2026
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
€327,989
Profits / Employee
€457,891
Market Cap
11.52B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
Moderna News
- 2 days ago - Life-saving therapies are being delayed as research funding dries up | Letter - The Guardian
- 4 days ago - Moderna just had its best day since October. Here's what's going on, and what analysts expect - CNBC
- 4 days ago - Moderna Stock Fights Back Against Four‑Year Curse With 20% Blastoff And A Golden Cross - Benzinga
- 4 days ago - UBS Lowers Moderna (MRNA) Price Target to $34, Rating Changed to Neutral | MRNA Stock News - GuruFocus
- 4 days ago - MRNA Crosses Above Average Analyst Target - Nasdaq
- 4 days ago - My Top 5 Stocks to Buy in Early 2026 - The Motley Fool
- 4 days ago - Moderna (MRNA) Soars 10.9%: Is Further Upside Left in the Stock? - Nasdaq
- 4 days ago - Tuesday Sector Leaders: Healthcare, Technology & Communications - Nasdaq